Correcting anemia or iron deficiency in patients with heart failure has been shown to improve mortality and quality of life. Among patients with heart failure, how common are anemia and iron deficiency? What type of iron supplementation therapy is most effective? Dr. William Dec, chief of the cardiology division, co-director of the Massachusetts General Hospital Heart Center, and the Roman W. DeSanctis Professor of Medicine at Harvard Medical School, discusses the Ferinject Assessment in Patients with Iron Deficiency and Chronic Heart Failure, or FAIR-HF, trial, and shares his excitement about this new potential pharmacologic therapy for patients with heart failure. Hosted by Dr. Alfred Bove.
